Veracyte VCYT Testing revenue — Laboratory supplies and reagents expense

Similar metrics at other companies

LHDiagnostics — Supplies Expense

$613.5M+4.6%

NTRAProduct revenues — Cost of revenues

$245.2M+32.8%

LHBiopharma Laboratory Services — Supplies Expense

$121.5M+9.4%

MTDLaboratory Related Products and Services — Revenue from Contract with Customer, Excluding Assessed Tax

$524.58M+4.9%

DGXTotal Cost of Revenue

$1.95B+9.2%

TMOLaboratory Products and Biopharma Services — Cost of revenues

$4.76B+7.9%

Questions, answered.

What is Veracyte's testing revenue — laboratory supplies and reagents expense?

Veracyte (VCYT) reported testing revenue — laboratory supplies and reagents expense of $12.31M in Q1 2026.

How has Veracyte's testing revenue — laboratory supplies and reagents expense changed year-over-year?

Veracyte's testing revenue — laboratory supplies and reagents expense decreased by 5.8% year-over-year, from $13.07M to $12.31M.

What is the long-term trend for Veracyte's testing revenue — laboratory supplies and reagents expense?

Over 3 years (2022 to 2025), Veracyte's testing revenue — laboratory supplies and reagents expense has grown at a 20.2% compound annual growth rate (CAGR), from $32.99M to $57.29M.

What does testing revenue — laboratory supplies and reagents expense mean?

This captures the variable costs associated with the physical materials, chemical reagents, and consumables required to perform diagnostic tests. It is a key component of the cost of goods sold for laboratory-based service providers.